In this controlled trial, patients referred to post-myocardial infarction cardiac rehabilitation will be randomized to either interval or continuous training.
The trial would i) compare the acute effects of each exercise type on selected cardiovascular indicators; ii) compare the chronic effects of each exercise type on selected cardiovascular indicators; iii) provide information on the association between acute and chronic effects of each exercise type; iv) provide insight into possible mechanisms of effectiveness of each exercise type; v) identify the most safe and effective exercise type for patients with coronary artery disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
115
Patients to be randomized to the 'interval training group' or 'continuous training group' will undergo exercise training sessions with different intensity levels.
University Medical Centre Ljubljana
Ljubljana, Slovenia
Change of flow-mediated dilatation of the brachial artery, measured in %
Time frame: 3 months
Change of the arterial stiffness coefficient
Time frame: 3 months
Change of maximal oxygen uptake during exercise, measured in ml/kg/min
Time frame: 3 months
Change of the heart rate variability
Time frame: 3 months
Change of the heart rate recovery
Time frame: 3 months
Change in health-related quality of life using SF-36 questionnaire, measured in points
It is a self-administered questionnaire comprising 36 items measuring eight dimensions and two subscales (physical and mental)
Time frame: 3 months
Change in IL-6, IL-8, IL-10, TNF-alpha and NT-proBNP levels, measured in ng/l
Time frame: 3 months
Change in osteopontin and D-dimer levels, measured in microg/l
Time frame: 3 months
Change in selectin and hsCRP, measured in mg/l
Time frame: 3 months
Change in hsTnI, CK MB, endocan, sST2, galectin-3, NGAL, CD40 ligand and BDNF, measured in ng/l
Time frame: 3 months
Change in copeptin levels, measured in pmol/l
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 3 months
Change in MR-proADM and MR-proANP, measured in nmol/l
Time frame: 3 months
Change in homoarginine, ADMA and SDMA levels, measured in micromol/l
Time frame: 3 months
Change in fibrinogen and Lp(a) levels, measured in mg/dl
Time frame: 3 months
Change in insuline level, measure in microIU/ml
Time frame: 3 months
Change in total cholesterol, LDL, HDL, triglycerides and glucose levels, measured in mmol/l
Time frame: 3 months
Change in overall haemostatic potential
Time frame: 3 months